Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
NCT05652322 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL
Last updated 2025-02-20
Summary
The goal of this clinical study is to compare treatment regimens of loop diuretics in patients with decompensated heart failure. The main aim is to answer if early change from intravenous to oral loop diuretics is safe and effective.
Conditions
Interventions
- DRUG
-
Furosemide Pill 150% equivalent iv dose
change from intravenous to oral furosemide
- DRUG
-
Furosemide Pill 200% equivalent iv dose
change from intravenous to oral furosemide
- DRUG
-
Furosemide Injection
change from intravenous to oral furosemide
Sponsors & Collaborators
-
Jan Kochanowski University
lead OTHER
Principal Investigators
-
Janusz Sielski, MD, PhD · Jan Kochanowski Univeristy in Kielce
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-07
- Primary Completion
- 2023-12-01
- Completion
- 2024-03-01
Countries
- Poland
Study Locations
More Related Trials
-
Dopamine in Acute Decompensated Heart Failure II
NCT01060293 ·Status: TERMINATED ·Phase: PHASE4
-
Sub-Q Versus IV Furosemide in Acute Heart Failure
NCT02579057 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
NCT03730961 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload
NCT03359161 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
NCT00283361 ·Status: TERMINATED ·Phase: PHASE2
-
Bumetanide Versus Furosemide in Heart Failure
NCT00372762 ·Status: WITHDRAWN ·Phase: PHASE3
-
Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)
NCT00577135 ·Status: COMPLETED ·Phase: PHASE3
-
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF
NCT02649998 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT04628325 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
NCT05940220 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients
NCT02689180 ·Status: UNKNOWN ·Phase: PHASE3
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
NCT03170219 ·Status: TERMINATED ·Phase: PHASE2
-
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
NCT02329834 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen
NCT02721511 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
NCT01705470 ·Status: WITHDRAWN ·Phase: NA
-
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
NCT01644331 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
NCT02047422 ·Status: WITHDRAWN ·Phase: NA
-
Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
NCT05419115 ·Status: COMPLETED ·Phase: PHASE2
-
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
NCT04384653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF
NCT06442280 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product
NCT02804282 ·Status: COMPLETED ·Phase: PHASE3
-
Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study
NCT04593823 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
NCT00937092 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral dIuretics in Very Intensive Treatment, an Early Intervention in Outpatients With Heart Failure
NCT03709160 ·Status: UNKNOWN ·Phase: PHASE4
-
Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes
NCT06475105 ·Status: RECRUITING ·Phase: PHASE4